Public Health England
Rapid evaluation confirms lateral flow devices effective in detecting new COVID-19 variant
Public Health England (PHE) has confirmed that lateral flow devices (LFDs) used in mass testing can detect the new COVID-19 variant.
Scientists at PHE’s Porton Down laboratory have carried out a rapid evaluation using clinical and laboratory grown samples containing the VUI 202012/01 variant to test whether it can be detected by lateral flow devices (LFDs) currently in use across the country.
Five LFDs were tested. Each device is either in use as part of mass testing or going through the final stages of validation at PHE. Each device successfully detected samples containing the new variant.
LFDs are one of the new tools being used to help detect COVID-19 and results can be delivered rapidly in under 30 minutes.
The devices can identify people who have high levels of virus but who do not have symptoms and would not otherwise be coming forward for a test. This is important as up to 1 in 3 people who have coronavirus never show any symptoms but may still be infectious.
Whereas the new variant affects the spike protein on the surface of the virus, the lateral flow devices tested work by detecting the nucleocapsid protein that is located inside the virus, which is less likely to be affected.
Dr Susan Hopkins, Senior Medical Advisor to PHE and NHS Test and Trace, said:
This rapid evaluation confirms that lateral flow devices can detect the new variant. This is good news as it means they can continue to be used to find people who have COVID-19 without symptoms who might be unknowingly passing it on.
Lateral flow devices alone aren’t a silver bullet for stopping the spread of the virus but we know they can help detect large numbers of positive cases quickly.
When used in combination with other infection prevention control measures, they are another vital tool to help us combat the spread of the virus.
Labs have been issued with guidance to ensure that PCR tests can detect this variant.
DHSC has not identified any issues with detection of the variant in its network of laboratories.
Latest News from
Public Health England
JCVI advises inviting people on Learning Disability Register for vaccine24/02/2021 15:10:00
JCVI has advised the government to invite all people on the GP Learning Disability Register for COVID-19 vaccination.
Fewer than 1 in 5 university students had COVID-19 by end of autumn term24/02/2021 12:25:00
A study conducted by Public Health England (PHE) estimates that 17.8% of university students in England had COVID-19 antibodies.
Vaping better than nicotine replacement therapy for stopping smoking, evidence suggests24/02/2021 10:10:10
As number of vapers in England plateaus, incorrect perceptions of its relative risks compared to smoking may be discouraging smokers from using vaping to quit.
First real-world UK data shows Pfizer-BioNTech vaccine provides high levels of protection from the first dose23/02/2021 10:10:10
PHE yesterday published the first independent analysis in the UK showing the Pfizer-BioNTech vaccine is effective against COVID-19 from the first dose.
PHE launches new Psychological First Aid training22/02/2021 15:10:00
The online training, developed by PHE, is now available for those supporting children and young people affected by coronavirus (COVID-19).
PHE statement on Variant of Concern and new Variant Under Investigation10/02/2021 11:25:00
NERVTAG has named one additional SARS-CoV-2 Variant Under Investigation and one additional Variant of Concern.
New Every Mind Matters campaign19/01/2021 10:10:10
The new campaign launches to support the nation’s mental health, as half of adults say they are more worried during this current lockdown than in March 2020.
Past COVID-19 infection provides some immunity but people may still carry and transmit virus15/01/2021 16:10:00
Study finds past coronavirus (COVID-19) infection provides some immunity for at least 5 months, but people may still carry and transmit the virus.